Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review

Prognostic factor testing among older women with ductal carcinoma in situ and early invasive breast cancer

Stephanie Jarosek  1 , Todd M Tuttle  2 , Sara Durham  1 , Beth A Virnig  1
In: Data Points Publication Series [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2011. Data Points # 15.
2012 Aug.
Affiliations
Free Books & Documents
Review

Prognostic factor testing among older women with ductal carcinoma in situ and early invasive breast cancer

Stephanie Jarosek et al.
Free Books & Documents

Excerpt

Estrogen receptor (ER) testing rates have increased over time for both ductal carcinoma in situ (DCIS) and early invasive cancers. However, rates of positive ER tests have not increased.

Rates of BRCA genetic testing are very low (<2%) for both DCIS and early invasive breast cancers.

Current guidelines do not recommend routine testing for human epidermal growth factor receptor 2 (HER2) for women with DCIS. Yet, rates of this testing increased between 2004 and 2007 in both DCIS and early invasive breast cancer groups.

Rates of testing varied significantly across race groups for all tests. However, the pattern of change differed between tests.

PubMed Disclaimer

References

    1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA: Cancer J Clin. 2012;62(1):10–29. - PubMed
    1. Patani N, Cutuli B, Mokbel K. Current management of DCIS: a review. Breast Cancer Res Treat. 2008;111(1):1–10. - PubMed
    1. Virnig BA, Shamliyan T, Tuttle TM, et al. Diagnosis and management of ductal carcinoma in situ (DCIS), Evidence Report/Technology Assessment No. 185. Rockville, MD: Agency for Healthcare Research and Quality; 2009. (prepared by the Minnesota Evidence-based Practice Center under Contract No. 290-02-10064-I) AHRQ Publication No. 09-E018. - PMC - PubMed
    1. NCCN clinical practice guidelines in oncology: breast cancer. Fort Washington, PA: National Comprehensive Cancer Network; 2011. - PubMed
    1. Virnig BA, Tuttle TM, Shamliyan T, Kane RL. Ductal carcinoma in situ of the breast: a systematic review of incidence, treatment, and outcomes. J Natl Cancer Inst. 2010;102(3):170–8. - PubMed

LinkOut - more resources